Simulations An Attractive Vehicle For Investors Seeking Exposure To Biotech Innovation Themes, Analyst Says
Portfolio Pulse from Nabaparna Bhattacharya
Oppenheimer analyst Francois Brisebois reiterated an Outperform rating on Simulations Plus, Inc. (NASDAQ:SLP) with a price target of $67. Brisebois sees SLP as an attractive investment for exposure to biotech innovation themes and data growth waves. The analyst is optimistic about SLP's 10-year growth trajectory and cash position. SLP reported 3Q23 with a top line of $16.2 million, mostly in line with estimates. The company's software revenue was $10.6 million. The analyst expects FY23 revenues of $60.67 million, up 12.6% Y/Y, and EPS of $0.64, up from $0.60 a year ago.
July 07, 2023 | 6:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer analyst Francois Brisebois reiterated an Outperform rating on Simulations Plus, Inc. (NASDAQ:SLP) with a price target of $67. The analyst is optimistic about SLP's 10-year growth trajectory and cash position. SLP reported 3Q23 with a top line of $16.2 million, mostly in line with estimates.
The analyst's positive outlook and the Outperform rating on SLP, along with the company's strong financial performance in 3Q23, are likely to have a positive impact on the stock's price in the short term. The company's growth trajectory and cash position also add to its attractiveness as an investment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100